Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...

About a fourth of younger men surveyed in the United States feel lonely, which is significantly higher than the national ...

The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...

A new COVID-19 vaccine has been approved, but it's not available to everyone. Aerial drone footage shows the humpback whale (Megaptera novaeangliae) missing its iconic lobed fluke, which is ...

The VRBPAC meeting comes the week after the World Health Organization (WHO) recommended that members consider using ...

Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's ...

The new framework was well-received by biopharma analysts, who say it “largely formalizes” current COVID-19 vaccination ...

COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Trump administration.

Additionally, the Department of Health and Human Services unveiled the framework for the Most Favored Nation drug pricing ...

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...